ECULIZUMAB

( DrugBank: Eculizumab / KEGG DRUG: Eculizumab )

---

8 diseases

11. 重症筋無力症

---

臨床試験数 : 525 / 薬物数 : 355 - (DrugBank : 80) / 標的遺伝子数 : 75 - 標的パスウェイ数 : 139 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,898 / 薬物数 : 2,785 - (DrugBank : 360) / 標的遺伝子数 : 265 - 標的パスウェイ数 : 239 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

14. 慢性炎症性脱髄性多発神経炎／多巣性運動ニューロパチー

---

臨床試験数 : 302 / 薬物数 : 231 - (DrugBank : 32) / 標的遺伝子数 : 16 - 標的パスウェイ数 : 67 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

61. 自己免疫性溶血性貧血

---

臨床試験数 : 218 / 薬物数 : 186 - (DrugBank : 42) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 158 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

62. 発作性夜間ヘモグロビン尿症

---

臨床試験数 : 380 / 薬物数 : 240 - (DrugBank : 38) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 122 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

109. 非典型溶血性尿毒症症候群

---

臨床試験数 : 130 / 薬物数 : 44 - (DrugBank : 5) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 11 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

221. 抗糸球体基底膜腎炎

---

臨床試験数 : 9 / 薬物数 : 12 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 22 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

223. 一次性膜性増殖性糸球体腎炎

---

臨床試験数 : 243 / 薬物数 : 296 - (DrugBank : 84) / 標的遺伝子数 : 46 - 標的パスウェイ数 : 169 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries